Stockscreener 앱 받기
7.51
9.32%
0.64
시간 외 거래:
7.52
0.010
+0.13%
Cvrx Inc 주식(CVRX)의 최신 뉴스
Methodist University Hospital completes first Barostim implant with CVRx collaboration - Traders Union
CVRx will post first-quarter results after the bell on May 11 - Stock Titan
CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
CVRx promotes Barostim therapy as new option for heart failure patients at ISHLT2026 - Traders Union
CVRx reports preliminary 2025 results, issues 2026 guidance - MSN
CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
CVRx nominates Michael Dale to board of directors By Investing.com - Investing.com India
CVRx nominates Michael Dale to board of directors - Investing.com
Lawnwood Medical Center achieves milestone with 15th Barostim therapy, CVRx confirms - Traders Union
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors - marketscreener.com
Former Abbott structural heart leader Michael Dale lands CVRx board nomination - Stock Titan
CVRx (CVRX) details 2026 virtual meeting, board nominees and pay - Stock Titan
Behavioral Patterns of CVRX and Institutional Flows - Stock Traders Daily
CVRX Should I Buy - Intellectia AI
CVRx unveils Barostim session on neurohormonal targeting at ISHLT2026 - Traders Union
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
CVRX Maintained by Canaccord Genuity -- Price Target Steady at $10 - GuruFocus
CVRx (NASDAQ:CVRX) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
CVRx Price Target Maintained With a $10.00/Share by Canaccord Genuity - Moomoo
Lake Street Remains a Buy on CVRx (CVRX) - The Globe and Mail
A Quick Look at Today's Ratings for CVRx Inc(CVRX.US), With a Forecast Between $10 to $14 - 富途牛牛
Lake Street Initiates CVRx Inc(CVRX.US) With Buy Rating, Announces Target Price $14 - 富途牛牛
William Blair reiterates CVRx stock rating on strong Q1 results By Investing.com - Investing.com Australia
William Blair reiterates CVRx stock rating on strong Q1 results - Investing.com
CVRx Reports 20% Revenue Growth and Improved Medicare Approval Rates in Preliminary Q1 2026 Results - Minichart
CVRx expects robust 20 percent revenue growth in preliminary Q1 results - Traders Union
CVRx Reports Strong Q1 Growth and Trial Progress - TipRanks
CVRx preliminary Q1 revenue rises 20%, gross margin improves - TradingView
CVRx (NASDAQ: CVRX) posts Q1 growth and advances BENEFIT-HF trial - Stock Titan
CVRx Reports Preliminary First Quarter 2026 Financial Results - marketscreener.com
CVRx says Medicare approval rates improved as heart device sales rose - Stock Titan
Forecast Cut: Is CVRX a speculative investmentCPI Data & AI Based Buy and Sell Signals - baoquankhu1.vn
Bear Alert: Is CVRx Inc stock overvalued or fairly priced2026 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
CVRx, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
(CVRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Pharma News: Will CVRX benefit from government policyDay Trade & Reliable Price Breakout Alerts - baoquankhu1.vn
Analysis Recap: Can CVRx Inc weather a recession2026 Price Action Summary & Trade Opportunity Analysis - baoquankhu1.vn
Is CVRx (CVRX) Stock Stable Now | Price at $9.19, Up 2.00%Profit Potential - Cổng thông tin điện tử Tỉnh Sơn La
CVRX Apr 2026 7.500 call (CVRX260417C00007500) Interactive Stock Chart - Yahoo! Finance Canada
CVRX Apr 2026 10.000 put (CVRX260417P00010000) Interactive Stock Chart - Yahoo! Finance Canada
CVRX Earnings History & Surprises | EPS & Revenue Results | CVRX INC (NASDAQ:CVRX) - ChartMill
CVRx, Inc. (NASDAQ:CVRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Patterns Watch: Is CVRX a speculative investmentPortfolio Profit Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Sectors Review: Is CVRX a strong candidate for buy and holdInsider Buying & Technical Analysis for Trade Confirmation - baoquankhu1.vn
IMA,CVRX Volatility & Greeks - Finviz
How (CVRX) Movements Inform Risk Allocation Models - Stock Traders Daily
CVRx touts Barostim therapy as improving exercise capacity in heart failure beyond GDMT alone - Traders Union
SGP,CVRX Volatility & Greeks - Finviz
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Shareholders to Reach Out - ACCESS Newswire
2026-03-26 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Shareholders to Reach Out | NDAQ:CVRX | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
CVRx, Inc. (NASDAQ:CVRX) Q4 2025 earnings call transcript - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
IMA,CVRX Dividends - Finviz
2.95%
자본화:
|
볼륨(24시간):